Authors



Andrew Smith

Latest:

JDRF's Kowalski Sees Hope in Bipartisan Support for Insulin Pricing Reform

Aaron Kowalski, PhD, the new CEO of the JDRF, says in a discussion about insulin pricing that action is needed not only by Congress, but also by insulin makers, health plans, and the executive branch. The most important goal: ending a crosspayment scheme that many blame for potentially deadly price increases.




Chung-Yin Sherman, CRNP

Latest:

Predictive Factors of Discharge Navigation Lag Time

Examination of factors associated with discharge lag time and how this metric plays an important role in managing hospital throughput.


Melissa S. Hernandez, MD

Latest:

Shared Medical Appointments for Patients with Type 2 Diabetes

Glycemic control in patients with type 2 diabetes was improved through a shared medical appointment program focusing on lifestyle education and behavior change.


Gary Liska, BS

Latest:

STABLE Results: Warfarin Home Monitoring Achieves Excellent INR Control

Real-world retrospective analysis of over 29,000 patients performing INR home monitoring for warfarin therapy shows excellent time in therapeutic range.



John M. Fontanesi, PhD

Latest:

Delivering Vaccines: A Case Study of the Distribution System of Vaccines for Children

During implementation of the Vaccine Management Business Improvement Project, providers experienced longer delivery delays and a higher probability of a Vaccines for Children stockout.



Luis Rodriguez, MD

Latest:

Randomized Trial of an Electronic Asthma Monitoring System Among New York City Children

Children who used an electronic monitoring system had as many emergency department visits and hospitalizations for asthma as children who used a paper diary.




Cara L. McDermott, BA

Latest:

Colony-Stimulating Factor Prescribing Patterns in Patients Receiving Chemotherapy for Cancer

We linked health insurance records to cancer registry data to analyze colony-stimulating factor use, finding wide divergence from that recommended by practice guidelines.


Jeff Dunn, PharmD, MBA

Latest:

Expert Panel: Access to Multiple Treatment Options Is Needed to Continue the Fight Against HIV

A multidisciplinary panel of HIV experts gathered in October 2016 to discuss the current state of HIV care and develop critical recommendations for Pharmacy and Therapeutics (P&T) committee members to consider when developing policies affecting their member populations who are living with HIV. This paper presents the panel’s discussion, consensus opinion, and conclusions.


Paulette Blanc, MPH

Latest:

Outpatient Referral Rates in Family Medicine

Referral patterns by family physicians affect numerous aspects of medical care. This study compares the outpatient referral rates of residents, residency faculty, and clinical faculty.



Kaveh G. Shojania, MD

Latest:

Automated Patient Assessments After Outpatient Surgery Using an Interactive Voice Response System

Using an interactive voice response system to contact patients after outpatient surgery will likely result in improved efficiency without a decrease in assessment quality.



Darren Kaiser, MS

Latest:

Implementation of EHR-Based Strategies to Improve Outpatient CAD Care

We examined the impact of electronic reminders followed by performance reports and financial incentives. Physicians responded more to reports and incentives than to reminders alone.


Terrie Fox Wetle, PhD

Latest:

Medicare Advantage Plan Representatives’ Perspectives on Pay for Success

This study examined how Medicare Advantage plan representatives perceive the alternative financing model Pay for Success and its potential to address members’ social risk factors.


Lloyd Myers, RPh

Latest:

Physician ePortfolio: The Missing Piece for Linking Performance With Improvement

Clinical data should contribute to practice-based learning and improvement, resulting in improved patient care as well as meeting increasingly rigorous physician accountability requirements.


Henry Yue, PharmD

Latest:

Clinical Consequences of Disseminating the Rosiglitazone FDA Safety Warning

Notifying patients and providers about the rosiglitazone cardiovascular safety alert led to sweeping changes in drug therapy that were initiated by both physicians and patients.


Sean R. Tunis, MD, MSc

Latest:

Proposed Framework for Patient-Centered Outcomes-Based Measures in Alternative Payment Models

Synthesis of multistakeholder perspectives from a mixed-methods study identifies guiding characteristics for outcomes-based quality measures in future, more patient-centered alternative payment models.


Brenna Diaz

Latest:

Collaborative and Convenient Care: Reevaluating Approaches to Diabetes Management

Coverage from Patient-Centered Diabetes Care, April 7-8, 2016. Presented by The American Journal of Managed Care and Joslin Diabetes Center.


Martin Beyer, MSocSc

Latest:

Performance of the Adapted Diabetes Complications Severity Index Translated to ICD-10

We present an International Classification of Diseases, Tenth Revision (ICD-10) translation of the adapted Diabetes Complications Severity Index and show its performance in predicting hospitalizations, mortality, and healthcare-associated costs.



Jisu Kim, MD

Latest:

Patient Safety Intervention to Reduce Unnecessary Red Blood Cell Utilization

This study evaluated the impact of a patient safety intervention and national guideline to reduce unnecessary red blood cell transfusions in a large, urban academic medical center.


Timothy J. Beebe, PhD

Latest:

Flunking Asthma? When HEDIS Takes the ACT

Asthma control, rather than compliance with the HEDIS asthma measure, is the most useful quality indicator of asthma care.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo